Tobin Juvenal
Corporate Officer/Principal en CASTLE BIOSCIENCES, INC. .
Fortuna: 982 504 $ al 30/04/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Derek Maetzold | M | 62 | 17 años | |
| Daniel Bradbury | M | 62 | 12 años | |
| G. Cole | M | 68 | 6 años | |
| Tiffany Olson | F | 64 | 3 años | |
| Kristen Oelschlager | F | 56 | 16 años | |
| Kimberlee Caple | F | 62 | 3 años | |
| Robert W. Cook | M | 52 | 13 años | |
| Ellen Goldberg | F | 50 | 3 años | |
| Miles Harrison | M | 59 | 4 años | |
| Camilla Zuckero | F | - | 5 años | |
| John Abbott | M | - | 10 años | |
| Kevin Doman | M | - | 2 años | |
| Chris Otte | M | - | - | |
| Keli Greenberg | F | - | 4 años | |
| John C. Cheneval | M | - | 3 años | |
| Noreen Manning | F | - | - | |
| Matthew Goldberg | M | - | 4 años | |
| Alice Bahner Izzo | F | - | 11 años | |
| Franklin Stokes | M | 54 | 7 años | |
| Johnson Clare | M | - | 3 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| George Cole | M | 75 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 3 años |
| David Kabakoff | M | 76 | - | |
| Bernhard E. Spiess | M | 64 | 5 años | |
| Patrick Hall | M | - | - | |
| Joseph Cook | M | 53 | 3 años | |
| Mara Aspinall | F | 61 | 9 años | |
| Bonnie Anderson | F | 66 | 5 años | |
| Paul S. Manierre | M | 70 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 6 años |
| Garheng Kong | M | 49 | 3 años | |
| Frank Charles Carlucci | M | 91 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | - |
| William Ringo | M | 78 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 6 años |
| Carl Sterritt | M | 55 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | - |
| Timothy Decker | M | - | - | |
| Federico A. Monzon | M | 56 | 5 años | |
| James L. Dunn | M | 62 | 2 años | |
| Elizabeth Ann Fagan | M | 74 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 2 años |
| Acosta Greg | M | - | 1 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 37 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Tobin Juvenal
- Red Personal
